Loading...
XNAS
TXG
Market cap2.24bUSD
Dec 04, Last price  
18.15USD
1D
1.57%
1Q
30.01%
IPO
-65.28%
Name

10X Genomics Inc

Chart & Performance

D1W1MN
XNAS:TXG chart
P/E
P/S
3.67
EPS
Div Yield, %
Shrs. gr., 5y
25.24%
Rev. gr., 5y
19.96%
Revenues
611m
-1.28%
71,085,000146,313,000245,893,000298,845,000490,490,000516,409,000618,727,000610,785,000
Net income
-183m
L-28.41%
-18,762,000-112,485,000-31,251,000-542,731,000-58,223,000-166,000,000-255,099,000-182,627,000
CFO
7m
P
-10,699,000-76,409,00034,627,000-217,898,000-21,373,000-33,606,000-15,197,0006,664,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
IPO date
Sep 12, 2019
Employees
1,243
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT